Mediterr J Rheumatol 2020;31(1):71-4
Regulation of microRNA in Systemic Lupus Erythematosus: the role of miR-21 and miR-210
Authors Information

Department of Rheumatology and Clinical Immunology, Faculty of Medicine, University of Thessaly, Larissa, Greece

  1. Kyttaris VC, Katsiari CG, Juang Y, Tsokos GC. New Insights into the Pathogenesis of Systemic Lupus Erythematosus. Cur Rheumatol Rep 2005;7:469-75.
  2. Katsiari CG, Liossis SN, Sfikakis PP. The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal. Semin Arthritis Rheum 2010;39(6):491-503. Epub 2009/01/17.
  3. Pauley KM, Cha S, Chan EK. MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 2009;32(3-4):189-94. Epub 2009/03/24.
  4. Keller A, Leidinger P, Bauer A, Elsharawy A, Haas J, Backes C, et al. Toward the blood-borne miRNome of human diseases. Nat Methods 2011;8(10):841-3. Epub 2011/09/06.
  5. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010;11(9):597-610. Epub 2010/07/28.
  6. Ma J, Lin Y, Zhan M, Mann DL, Stass SA, Jiang F. Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer. Lab Invest 2015;95(10):1197-206. Epub 2015/07/07.
  7. Shen N, Liang D, Tang Y, de Vries N, Tak PP. MicroRNAs--novel regulators of systemic lupus erythematosus pathogenesis. Nat Rev Rheumatol 2012;8(12):701-9. Epub 2012/10/17.
  8. Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009;60(4):1065-75. Epub 2009/04/01.
  9. Zhao S, Wang Y, Liang Y, Zhao M, Long H, Ding S, et al. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum 2011;63(5):1376-86. Epub 2011/05/04.
  10. Stagakis E, Bertsias G, Verginis P, Nakou M, Hatziapostolou M, Kritikos H, et al. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis 2011;70(8):1496-506. Epub 2011/05/24.
  11. Katsiari CG Liossis S-N, Dimopoulos AM, Charalambopoulos DV, Mavrikakis M, Sfikakis PP. CD40L overexpression on T cells and monocytes from patients with systemic lupus erythematosus is resistant to calcineurin inhibition. Lupus 2002;11:370- 8.
  12. Katsiari CG, Liossis SN, Souliotis VL, Dimopoulos AM, Manoussakis MN, Sfikakis PP. Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus. Clin Immunol 2002;103(1):54-62. Epub 2002/05/04.
  13. Lashine YA SS, Aboelenein HR, Abdelaziz AI. Correcting the expression of miRNA-155 represses PP2Ac and enhances the release of IL-2 in PBMCs of juvenile SLE patients. Lupus 2015;24:240-7.
  14. Katsiari CG, Kyttaris VC, Juang YT, Tsokos GC. Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. J Clin Invest 2005;115(11):3193-204. Epub 2005/10/15.
  15. Mace TA, Collins AL, Wojcik SE, Croce CM, Lesinski GB, Bloomston M. Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells. J Surg Res 2013;184(2):855-60. Epub 2013/06/04.
  16. Semenza GL. Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim Biophys Acta 2011;1813(7):1263-8. Epub 2010/08/25.
  17. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 2012;148(3):399-408. Epub 2012/02/07.
  18. Yang ZC, Liu Y. Hypoxia-Inducible Factor-1alpha and Autoimmune Lupus, Arthritis. Inflammation 2016;39(3):1268-73. Epub 2016/04/02.
  19. Gorelik G, Richardson B. Key role of ERK pathway signaling in lupus. Autoimmunity 2010;43(1):17-22. Epub 2009/12/08.
  20. Hickman SP, Yang J, Thomas RM, Wells AD, Turka LA. Defective Activation of Protein Kinase C and Ras-ERK Pathways Limits IL-2 Production and Proliferation by CD4+CD25+ Regulatory T Cells. J Immunol 2006;177(4):2186-94.
  21. Martin JC, Baeten DL, Josien R. Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus. Clin Immunol 2014;154(1):1-12. Epub 2014/05/27.
  22. Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 2011;146(5):772-84. Epub 2011/08/30.
  23. Zhao M, Wang LT, Liang GP, Zhang P, Deng XJ, Tang Q, et al. Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris. Clin Immunol 2014;150(1):22-30. Epub 2013/12/10.
  24. Dai Y, Sui W, Lan H, Yan Q, Huang H, Huang Y. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 2009;29(7):749-54. Epub 2008/11/11.
  25. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol 2019 Sep;71(9):1400-1412. doi:10.1002/art.40930.
  26. Stoll T, Seifert B, Isenberg DA. SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 1996 Mar;35(3):248-54.